BLOG / 🇮🇳 India / index intelligence · · daily

BSE FMCG Sector Regulatory Filings — November 02, 2026

India BSE FMCG

By Gunpowder Editorial ·

5 high priority 7 medium priority 12 total filings analysed

Executive Summary

The November 2, 2026 BSE FMCG filings reveal a sector navigating a sharp divergence between optical revenue growth and underlying profitability, dominated by ITC's post-excise-tax distortion and Marico's acquisition-driven transformation.

ITC's standalone revenue surged 45.7% YoY to ₹28,318 Cr, but this was almost entirely optical due to a ₹9,917 Cr excise duty jump following the February 2026 cigarette tax hike, while standalone PAT fell 20.1% YoY to ₹4,137 Cr and FMCG-Cigarettes segment results collapsed 27% to ₹3,813 Cr. Marico presented a similarly mixed picture: Q2 consolidated revenue declined 1.5% YoY to ₹3,897 Cr and PAT fell 14.4% to ₹558 Cr, yet management's market update highlighted 13% underlying revenue growth, 10% domestic volume growth, and 200 bps EBITDA margin expansion to 18.2%, with H1 FY27 revenue up 17.7% and PAT up 28% aided by the Skinetiq and Plix acquisitions. Working capital emerged as a cross-cutting concern: Marico's net working capital days rose to 33 from 26 QoQ and inventory days jumped to 50 from 40, while ITC's Agri Business faced West Asia conflict disruptions and lower leaf tobacco demand. Governance and strategic actions were also prominent: Marico appointed former HUL MD & CEO Rohit Jawa as an Independent Director effective January 1, 2027, and ITC approved the amalgamation of Sproutlife Foods (Yoga Bar) effective April 1, 2026. United Spirits and United Breweries filed only routine investor-meeting and transcript notices with no financial data, while Tata Consumer's ESG rating disclosure carries no financial impact. Overall, the filings signal a sector where volume-led FMCG growth is intact but margin pressure from tax shocks, acquisition integration costs, and working capital strain demands selective stock picking.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Corporate governance · Board meeting · Company update

Tracking the trend? Catch up on the prior BSE FMCG Sector Regulatory Filings digest from October 30, 2026.

Investment Signals (12)

  • Marico ↓ (BULLISH)
    ▲

    Underlying Q2 FY27 revenue grew 13% YoY with 10% domestic volume growth and 13% international CCG, driving EBITDA up 27% to ₹709 Cr and 200 bps margin expansion to 18.2%, despite reported consolidated revenue declining 1.5% due to portfolio mix

  • Marico ↓ (BULLISH)
    ▲

    H1 FY27 consolidated PAT grew 28.0% YoY to ₹1,210 Cr on revenue up 17.7% to ₹7,854 Cr, demonstrating strong first-half momentum despite Q2 softness

  • Marico ↓ (BULLISH)
    ▲

    Standalone Q2 PAT jumped 48.5% YoY to ₹683 Cr on higher other income of ₹330 Cr vs ₹171 Cr, providing a cushion to consolidated earnings

  • Marico ↓ (BULLISH)
    ▲

    Post-period agreement on October 5, 2026 to acquire an additional 38.18% of Satiya Nutraceuticals (Plix), taking holding to 84.09% fully diluted, expands the foods and nutraceuticals portfolio

  • Marico ↓ (BULLISH)
    ▲

    Board appointed Rohit Jawa, former MD & CEO of Hindustan Unilever (June 2023-July 2025) and President Unilever South Asia, as Independent Director for a 5-year term from January 1, 2027, signaling strong governance and strategic depth

  • ITC ↓ (BULLISH)
    ▲

    FMCG-Others segment results improved to ₹558.30 Cr from ₹436.85 Cr YoY, and Paperboards, Paper & Packaging rose to ₹281.93 Cr from ₹191.01 Cr aided by the Century Pulp and Paper acquisition completed August 1, 2026

  • ITC ↓ (BULLISH)
    ▲

    Consolidated revenue rose 19% YoY (LTL 17.3%, ex-Atta 23%) with EBITDA margin expanding 50 bps, marking the 4th consecutive quarter of double-digit growth, led by FMCG at a 14-quarter high and Paper segment revenue up 36% YoY

  • ITC ↓ (BULLISH)
    ▲

    Board approved amalgamation of wholly owned subsidiary Sproutlife Foods (Yoga Bar) with ITC effective April 1, 2026, simplifying the corporate structure with no new shares issued and no change to shareholding pattern

  • ITC ↓ (NEUTRAL)
    ▲

    Consolidated six-month PAT of ₹8,738.12 Cr was boosted by a one-time ₹405.88 Cr gain on remeasurement of the Sproutlife stake, though underlying standalone six-month PAT fell to ₹7,715.94 Cr from ₹10,086.43 Cr

  • ▲

    Scheduled four institutional investor conferences in November 2026 (Ashika on Nov 5, CITIC CLSA on Nov 16, JM Financial on Nov 18, Avendus Spark), indicating active engagement with the investment community

  • Received an independent ESG rating of 64.72/100 for FY 2025-26 from Niche99 ESG Ratings, prepared using publicly available data without company engagement, reflecting external validation of sustainability practices

  • Q2 FY2026-27 earnings call was held on October 28, 2026, with the transcript filed under SEBI Regulation 30, indicating timely disclosure and transparency

Risk Flags (10)

  • ITC↓ [HIGH RISK]
    ▼

    Standalone PAT fell 20.1% YoY to ₹4,137.12 Cr from ₹5,175.70 Cr, and PBT declined 19.9% to ₹5,481.75 Cr, as the February 2026 cigarette tax hike drove excise duty to ₹9,916.65 Cr from ₹1,360.74 Cr, severely pressuring the FMCG-Cigarettes segment

  • ITC↓ [HIGH RISK]
    ▼

    FMCG-Cigarettes segment results collapsed 27.2% YoY to ₹3,813.45 Cr from ₹5,240.66 Cr, with legal industry volumes under pressure from an unprecedented tax increase and sharp increases in smuggled cigarette seizures

  • ITC↓ [MEDIUM RISK]
    ▼

    Agri Business six-month revenue fell to ₹12,533.75 Cr from ₹13,661.27 Cr YoY, hampered by West Asia conflict-led disruptions and lower domestic leaf tobacco demand tied to the cigarette tax hike

  • ITC↓ [MEDIUM RISK]
    ▼

    The Tobacco Board announced a significant reduction in FCV tobacco crop size, which is likely to severely impact Indian tobacco farmers' earnings and could disrupt the agri supply chain

  • Marico↓ [MEDIUM RISK]
    ▼

    Consolidated net profit fell 14.4% YoY to ₹558 Cr from ₹652 Cr in Q2 FY27, with PBT down 14.7% to ₹674 Cr, despite underlying revenue growth, as advertisement and sales promotion spend jumped 44% to ₹451 Cr

  • Marico↓ [MEDIUM RISK]
    ▼

    Working capital stretched significantly, with net working capital days rising to 33 from 26 QoQ, inventory days up to 50 from 40, and debtor days up to 36 from 31, indicating deteriorating cash conversion

  • Marico↓ [MEDIUM RISK]
    ▼

    Consolidated inventories jumped to ₹2,297 Cr as at September 30, 2026 from ₹1,611 Cr as at March 31, 2026, and current borrowings rose to ₹1,046 Cr from ₹355 Cr, increasing balance sheet risk

  • Marico↓ [MEDIUM RISK]
    ▼

    Saffola Edible Oils, representing 16% of India revenues, declined approximately 1% in value terms in Q2 FY27, signaling weakness in a key domestic franchise

  • Marico↓ [LOW RISK]
    ▼

    Consolidated finance cost increased to ₹24 Cr in Q2 FY27 from ₹12 Cr in Q2 FY26, and depreciation rose to ₹64 Cr from ₹47 Cr, reflecting acquisition-related leverage and asset base expansion

  • ITC↓ [MEDIUM RISK]
    ▼

    Standalone revenue growth of 45.7% YoY is largely optical and not comparable due to the excise duty surge, which may mislead investors relying on headline growth

Opportunities (10)

  • Marico↓ (OPPORTUNITY)
    ◆

    The 200 bps EBITDA margin expansion to 18.2% and 27% EBITDA growth in Q2 FY27, despite reported revenue decline, suggests underlying operational strength that could drive re-rating once acquisition-related comparability issues normalize

  • Marico↓ (OPPORTUNITY)
    ◆

    The acquisition of an additional 38.18% of Plix (Satiya Nutraceuticals) for a total holding of 84.09% positions the company in the high-growth nutraceuticals segment, with the remaining 14.09% due July 2027 providing a clear path to full ownership

  • Marico↓ (OPPORTUNITY)
    ◆

    The appointment of Rohit Jawa, a seasoned consumer goods leader with 38 years of experience including as HUL MD & CEO, as Independent Director from January 1, 2027, could bring strategic insights and enhance board effectiveness

  • ITC↓ (OPPORTUNITY)
    ◆

    FMCG-Others segment delivered a 14-quarter-high performance with segment results of ₹558.30 Cr vs ₹436.85 Cr YoY, and the 4th consecutive quarter of double-digit consolidated revenue growth (19% YoY, LTL 17.3%) signals a durable growth trajectory in the non-cigarette FMCG business

  • ITC↓ (OPPORTUNITY)
    ◆

    The Paperboards, Paper & Packaging segment revenue grew 36% YoY (LTL 10%) with segment results of ₹281.93 Cr vs ₹191.01 Cr, aided by the Century Pulp and Paper acquisition, offering a diversification hedge against cigarette tax volatility

  • ITC↓ (OPPORTUNITY)
    ◆

    The amalgamation of Sproutlife Foods (Yoga Bar) into ITC effective April 1, 2026, simplifies the structure and integrates a growing brand, with no dilution to shareholders

  • ITC↓ (OPPORTUNITY)
    ◆

    The one-time ₹405.88 Cr gain on remeasurement of the Sproutlife stake boosted consolidated six-month PAT, and the underlying FMCG-Others momentum could drive further re-rating as the cigarette tax impact annualizes

  • United Spirits↓ (OPPORTUNITY)
    ◆

    The schedule of four institutional investor conferences in November 2026 (Nov 5, 16, 18, and Avendus Spark) provides multiple catalysts for management to communicate strategy and potentially positive updates to the investment community

  • United Breweries↓ (OPPORTUNITY)
    ◆

    The Q2 FY2026-27 earnings call transcript filed on October 28, 2026, may contain forward-looking guidance and operational insights that could reveal turnaround prospects or margin trends for the beer industry

  • ◆

    The independent ESG rating of 64.72/100 from Niche99, based on FY 2025-26 public data, could attract ESG-focused funds and improve the stock's sustainability perception, though the company did not engage the agency

Sector Themes (6)

  • Tax-Induced Optical Growth Distortion
    ◆

    ITC's 45.7% standalone revenue growth is almost entirely driven by a ₹8,556 Cr increase in excise duty (₹9,916.65 Cr vs ₹1,360.74 Cr), while underlying PAT fell 20.1%, highlighting how regulatory tax shocks can mask true operating performance in the FMCG sector and require investors to focus on segment results and volumes [IMPLICATION: Scrutinize excise-adjusted revenue and PAT trends]

  • Acquisition-Driven Portfolio Reshaping
    ◆

    Marico completed the Skinetiq acquisition (75% stake, effective April 2, 2026) and increased its Plix holding to 84.09%, while ITC integrated Century Pulp and Paper (completed August 1, 2026) and is amalgamating Sproutlife; these moves expand addressable markets but also introduce integration costs, higher finance costs (Marico's finance cost doubled to ₹24 Cr), and working capital strain [IMPLICATION: Near-term margin pressure but long-term growth optionality]

  • Working Capital Tightening
    ◆

    Marico's net working capital days rose to 33 from 26 QoQ, inventory days jumped to 50 from 40, and debtor days increased to 36 from 31, while ITC's Agri Business faced disruptions; this suggests a sector-wide cash conversion cycle elongation that could pressure free cash flow and dividend capacity [IMPLICATION: Monitor cash flow statements for deterioration]

  • Premiumization and Nutraceuticals Push
    ◆

    Marico's Plix acquisition and ITC's Yoga Bar amalgamation reflect a broader FMCG shift toward health and wellness categories, with Marico's foods portfolio and ITC's FMCG-Others segment (14-quarter high) benefiting from premiumization [IMPLICATION: Companies with strong nutraceutical/health food portfolios may command higher growth multiples]

  • Governance Upgrades and Board Strengthening
    ◆

    Marico's appointment of Rohit Jawa (ex-HUL MD & CEO) as Independent Director and ITC's board approval of the Sproutlife amalgamation indicate a focus on governance and strategic clarity, which could enhance investor confidence and reduce perceived risk [IMPLICATION: Positive for long-term institutional ownership]

  • ESG and Transparency Focus
    ◆

    Tata Consumer's disclosure of an independent ESG rating (64.72/100) and United Spirits/United Breweries' proactive investor conference and transcript filings reflect increasing emphasis on transparency and sustainability metrics, aligning with global investor expectations [IMPLICATION: Companies with strong ESG profiles may attract dedicated fund flows]

Watch List (9)

  • 👁

    Q2 FY27 earnings call audio recording was made available on November 2, 2026; watch for management commentary on Saffola Edible Oils decline, working capital normalization, and integration of Skinetiq and Plix acquisitions [Date: November 2, 2026]

  • 👁

    Rohit Jawa's appointment as Independent Director is subject to shareholder approval via postal ballot; watch for the outcome and any further board changes [Date: Postal ballot, likely Q3 FY27]

  • 👁

    The remaining 14.09% stake in Satiya Nutraceuticals (Plix) is due for acquisition in July 2027; monitor for valuation and funding details [Date: July 2027]

  • 👁

    The amalgamation of Sproutlife Foods with ITC is subject to approvals and effective April 1, 2026; watch for regulatory approvals and integration updates [Date: Expected completion in FY27]

  • 👁

    The cigarette business faces continued volume pressure from the February 2026 tax hike; monitor monthly GST collections and legal industry volume trends for signs of stabilization [Ongoing]

  • 👁

    The significant reduction in FCV tobacco crop size announced by the Tobacco Board could impact Agri Business revenues and farmer earnings; watch for Q3 FY27 Agri segment performance [Date: Q3 FY27 results]

  • Four investor conferences scheduled in November 2026 (Ashika on Nov 5, CITIC CLSA on Nov 16, JM Financial on Nov 18, Avendus Spark); watch for management guidance on volume growth and premiumization [Dates: November 5, 16, 18, 2026]

  • Q2 FY2026-27 earnings call transcript filed on October 28, 2026; watch for commentary on beer demand, input costs, and margin outlook [Date: Transcript available now]

  • The independent ESG rating of 64.72/100 for FY 2025-26 may be followed by other agency ratings; monitor for changes in ESG scores and potential inclusion in ESG indices [Ongoing]

Filing Analyses (12)
Marico Limited Corporate Governance mixed materiality 8/10

02-11-2026

Marico reported Q2 FY27 consolidated revenue from operations of ₹3,897 Cr, down 1.5% YoY from ₹3,957 Cr, while net profit fell 14.4% YoY to ₹558 Cr from ₹652 Cr as PBT declined 14.7% to ₹674 Cr. For H1 FY27, revenue rose 17.7% YoY to ₹7,854 Cr and PAT grew 28.0% to ₹1,210 Cr, helped by the Skinetiq acquisition (75% stake, effective April 2, 2026) and Beardo/Just Herbs integrations, though the company notes periods are not comparable. The filing also disclosed a post-period agreement (October 5, 2026) to acquire 38.18% of Satiya Nutraceuticals (Plix), taking its holding to 84.09% on a fully diluted basis, with the remaining 14.09% due July 2027.

  • · Consolidated advertisement and sales promotion expense rose to ₹451 Cr in Q2 FY27 from ₹313 Cr in Q2 FY26 (restated), while other expenses rose to ₹456 Cr from ₹362 Cr
  • · Consolidated finance cost increased to ₹24 Cr in Q2 FY27 from ₹12 Cr in Q2 FY26; depreciation rose to ₹64 Cr from ₹47 Cr
  • · Consolidated inventories jumped to ₹2,297 Cr as at September 30, 2026 from ₹1,611 Cr as at March 31, 2026; current borrowings rose to ₹1,046 Cr from ₹355 Cr
  • · Consolidated net cash from operating activities fell to ₹692 Cr in H1 FY27 from ₹701 Cr in H1 FY26; net cash used in investing was ₹878 Cr vs ₹600 Cr generated in H1 FY26
  • · Standalone revenue from operations was ₹2,722 Cr in Q2 FY27 vs ₹2,510 Cr in Q2 FY26 (restated), and standalone net profit was ₹683 Cr vs ₹398 Cr
  • · Standalone other income surged to ₹330 Cr in Q2 FY27 from ₹171 Cr in Q2 FY26
  • · Marico acquired 75% of Skinetiq (Vietnam digital-first entity) effective April 2, 2026, with an obligation to acquire NCI stake contingent on business milestones
  • · Beardo business undertaking vested in the Company effective June 29, 2026; Just Herbs vested effective October 1, 2025 (common control transactions)
  • · Customer-related advertisement and promotional expenses were reclassified as a net-off against revenue, applied retrospectively, with no impact on PBT, PAT, EPS or equity
  • · Dividends paid to shareholders were ₹519 Cr in H1 FY27 vs ₹908 Cr in H1 FY26
  • · Overseas consumer products portfolio contributes about 24% of Group revenue; FY2025-26 turnover was ₹136.1 billion (USD 1.5 billion)
  • · Marico touches the lives of 1 out of every 3 Indians
Marico Limited Market Notice neutral materiality 6/10

02-11-2026

Marico Limited's Board approved the appointment of Mr. Rohit Jawa (DIN: 10063590) as an Additional Director in the capacity of Independent Director for a 5-year term from January 1, 2027 to December 31, 2031, subject to shareholder approval via postal ballot. Mr. Jawa brings over 38 years of consumer-business leadership experience, most recently as Managing Director & CEO of Hindustan Unilever Limited (June 2023 to July 2025) and President, Unilever South Asia. The filing contains no financial results or monetary figures, so no period-over-period performance comparison applies.

  • · Mr. Jawa served as MD & CEO of Hindustan Unilever Limited from June 2023 until July 2025 and was a member of the Unilever Leadership Executive
  • · He previously served as Chief of Transformation for Unilever in London and as Executive Vice President, North Asia, and Chairman of Unilever China
  • · As Chairman and CEO of Unilever Philippines, he led the business into Unilever's top ten markets globally
  • · He holds a bachelor's degree from St. Stephen's College and an MBA from the Faculty of Management Studies, University of Delhi, plus IMD (2018) and Harvard Business School (2022) executive programs
  • · Mr. Jawa currently holds no directorship or Board Committee membership/chairmanship in any other company
  • · The appointment is based on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval
  • · Mr. Jawa is not related to any Director of the Company and is not debarred by any SEBI order
  • · Scrip Code: 531642; Scrip Symbol: MARICO
Marico Limited Market Update mixed materiality 8/10

02-11-2026

Marico reported Q2 FY27 consolidated revenue from operations of ₹3,897 Cr, down 1.5% YoY from ₹3,957 Cr, while net profit fell 14.4% YoY to ₹558 Cr from ₹652 Cr despite a sharp jump in advertisement and sales promotion spend (₹451 Cr vs ₹327 Cr). H1 FY27 revenue rose 17.7% YoY to ₹7,854 Cr and PAT grew 28.0% to ₹1,210 Cr, though results include the Skinetiq acquisition (75% stake, effective April 2, 2026) and are not comparable with prior periods. Standalone Q2 revenue declined 2.6% YoY to ₹2,722 Cr but standalone PAT jumped 48.5% to ₹683 Cr on higher other income (₹330 Cr vs ₹171 Cr).

  • · Consolidated total expenses rose to ₹3,276 Cr in Q2 FY27 from ₹2,949 Cr in Q2 FY26, with finance cost up to ₹24 Cr from ₹12 Cr and depreciation up to ₹64 Cr from ₹47 Cr
  • · Consolidated tax expense fell to ₹116 Cr in Q2 FY27 from ₹138 Cr, aided by a deferred tax credit of ₹95 Cr
  • · Consolidated inventories jumped to ₹2,297 Cr as at 30 Sep 2026 from ₹1,611 Cr as at 31 Mar 2026; trade receivables rose to ₹1,705 Cr from ₹1,304 Cr
  • · Consolidated current borrowings increased to ₹1,046 Cr as at 30 Sep 2026 from ₹355 Cr as at 31 Mar 2026
  • · Consolidated net cash from operating activities fell to ₹692 Cr in H1 FY27 from ₹701 Cr in H1 FY26; working capital change was an outflow of ₹640 Cr vs ₹313 Cr
  • · Consolidated cash and cash equivalents declined to ₹336 Cr as at 30 Sep 2026 from ₹404 Cr as at 31 Mar 2026
  • · Marico acquired 75% of Skinetiq Joint Stock Company (Vietnam digital-first brand) effective April 2, 2026; results are not comparable with prior periods
  • · Post-period, definitive agreements dated October 5, 2026 cover acquisition of 38.18% stake in Satiya Nutraceuticals (Plix); 24.09% acquired already, taking holding to 84.09% fully diluted, with remaining 14.09% due July 2027
  • · Customer-related advertisement and promotional expenses were reclassified from Advertisement and Sales Promotion to a net-off against Revenue from Operations, applied retrospectively with no impact on PBT, PAT, EPS or equity
  • · Standalone other income surged to ₹330 Cr in Q2 FY27 from ₹171 Cr in Q2 FY26, largely dividend income from subsidiaries
  • · Standalone H1 FY27 net profit declined to ₹1,143 Cr from ₹1,171 Cr in H1 FY26 (-2.4%)
  • · FY2025-26 turnover was ₹136.1 billion (USD 1.5 billion); overseas consumer products contribute about 24% of Group revenue
United Breweries Limited Analyst/Investor Meet neutral materiality 2/10

02-11-2026

United Breweries Limited filed the transcript of its Q2FY2026-27 earnings call, held on October 28, 2026, with BSE and NSE under SEBI Regulation 30. The filing itself is a procedural intimation containing only a weblink to the transcript, with no financial figures disclosed in the letter. No period-over-period performance data is available in this document.

  • · Earnings call for Q2FY2026-27 was held on October 28, 2026
  • · Transcript weblink reference: Q2_FY2026-2027_Financial_Results_Transcript
  • · BSE scrip code 532478; NSE symbol UBL
  • · Corporate Identity Number: L36999KA1999PLC025195
  • · Registered office: UB Tower, UB City, #24, Vittal Mallya Road, Bengaluru – 560 001
  • · Filing signed and digitally authenticated on 2026.11.02 at 15:20:41 +05'30'
Marico Limited Market Notice positive materiality 8/10

02-11-2026

Marico reported Q2 FY27 consolidated revenue of ₹3,897 Cr, up 13% YoY, with domestic volume growth of 10% and international CCG of 13%, driving EBITDA up 27% to ₹709 Cr (200 bps margin expansion to 18.2%) and PAT up 31% to ₹550 Cr. However, Saffola Edible Oils (16% of India revenues) declined ~1% in value, and working capital stretched with net working capital days rising to 33 from 26 and inventory days up to 50 from 40. H1 FY27 revenue grew 18% to ₹7,854 Cr with PAT up 28% to ₹1,180 Cr.

  • · Saffola Edible Oils (16% of India revenues) declined ~1% in Q2 value terms
  • · Net working capital days rose to 33 from 26 QoQ; inventory days up to 50 from 40; debtor days up to 36 from 31
  • · Material cost rose 1% YoY to ₹2,022 Cr in Q2; ASP spend jumped 44% to ₹451 Cr
  • · Copra prices fell 31% YTD YoY while Liquid Paraffin rose 91%, HDPE +22% and Rice Bran Oil +54%
  • · Market shares (MAT Sep'26): Parachute Rigids 60%, Saffola Oats 42%, VAHO 30%, Leave-on Serums 44%, Hair Gels/Waxes/Creams 50%
  • · Medium-term vision targets ₹20K+ Crore topline by 2030 with mid-teen EBITDA CAGR
  • · Premium + Digital share of portfolio targeted to rise from 37% (FY26) to 50% (FY30)
  • · International business CCG: Q2 13%, H1 14%
  • · 7 of last 10 quarters delivered high-single digit India volume growth; 9 of 10 delivered teens or higher international CCG
United Spirits Limited Analyst/Investor Meet neutral materiality 2/10

02-11-2026

United Spirits Limited disclosed its schedule of analyst and institutional investor meetings for November 2026, covering four conferences: the Ashika Institutional Equities Investor Conference (Thursday, 5th November 2026), the 29th CITIC CLSA India Forum 2026 (Monday, 16th November 2026), the 17th Annual India Conference – JM Financial India Xchange 2026 (Wednesday, 18th November 2026), and the Avendus Spark INDX Annual Investor Conference – Nov 2026. The filing explicitly states that no unpublished price sensitive information is proposed to be shared during these conferences, and the schedule remains subject to change due to exigencies. The disclosure contains no financial or operational performance data, making it a routine compliance intimation under Regulation 30 of SEBI LODR Regulations, 2015.

  • · Meeting types include Group & One to One sessions for the Ashika Institutional Equities conference
  • · Scrip Code: 532432 on BSE and UNITDSPR on NSE
  • · Corporate Identity Number: L01551KA1999PLC024991
  • · Registered office located at UB Tower, #24, Vittal Mallya Road, Bengaluru 560 001
  • · Filing digitally signed by Pragya Kaul on 2026.11.02 at 16:09:44 +05:30
TATA CONSUMER PRODUCTS LIMITED Market Notice neutral materiality 2/10

02-11-2026

Tata Consumer Products Limited disclosed via a Regulation 30 market notice that Niche Ninety-Nine Capability and Certifications (OPC) Private Limited ("Niche99 ESG Ratings") assigned the Company an ESG rating of 64.72/100 for FY 2025-26, based on information received October 17, 2026. The Company clarified it did not engage Niche99 for this rating and that the agency independently prepared the report using publicly available FY 2025-26 data. The disclosure is a routine compliance intimation with no financial or operational impact on the Company.

  • · Information on the ESG rating was received by the Company on October 17, 2026
  • · The Company has not engaged Niche99 ESG Ratings for ESG rating services
  • · The rating was independently prepared by Niche99 based on data pertaining to FY 2025-26 available in the public domain
  • · Disclosure made under Regulation 30 read with Schedule III of SEBI Listing Regulations and SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
  • · Scrip codes: NSE – TATACONSUM; BSE – 500800; Calcutta Stock Exchange – 10000027 (Demat) and 27 (Physical)
  • · Company CIN: L15491WB1962PLC031425
ITC Limited Board Meeting mixed materiality 9/10

02-11-2026

ITC reported Q2 FY27 standalone revenue from operations of ₹28317.67 Crore, up ~45.7% YoY from ₹19441.50 Crore, but the growth is largely optical — a sharp increase in Excise duty (₹9916.65 Crore vs ₹1360.74 Crore) following the February 2026 cigarette tax hike makes revenue non-comparable, and standalone PAT fell 20.1% YoY to ₹4137.12 Crore from ₹5175.70 Crore. FMCG-Cigarettes segment results declined to ₹3813.45 Crore from ₹5240.66 Crore, dragging total segment results down to ₹5156.55 Crore from ₹6320.72 Crore, while FMCG-Others improved (₹558.30 Crore vs ₹436.85 Crore) and Paperboards, Paper & Packaging rose to ₹281.93 Crore from ₹191.01 Crore, aided by the Century Pulp and Paper acquisition completed 1 August 2026. Consolidated PAT was ₹4229.33 Crore versus ₹5186.55 Crore, with the six-month consolidated figure boosted by a one-time ₹405.88 Crore gain on remeasurement of the Sproutlife stake.

  • · Standalone gross revenue from sale of products and services rose to ₹28152.21 Crore from ₹19207.82 Crore, but excise duty jumped to ₹9916.65 Crore from ₹1360.74 Crore after the February 2026 cigarette tax hike, making periods non-comparable
  • · Standalone six-month PAT fell to ₹7715.94 Crore from ₹10086.43 Crore; consolidated six-month PAT was ₹8738.12 Crore vs ₹10529.96 Crore
  • · Agri Business segment revenue declined to ₹4451.69 Crore from ₹3976.24 Crore in Q2 but six-month revenue fell to ₹12533.75 Crore from ₹13661.27 Crore
  • · Consolidated 'Others' segment results fell to ₹176.10 Crore from ₹182.65 Crore YoY
  • · Standalone 'Others' segment posted a loss of ₹7.80 Crore vs ₹6.90 Crore
  • · Net cash from operating activities (standalone) improved to ₹7765.58 Crore from ₹5738.67 Crore in H1
  • · Dividend paid during H1 FY27 was ₹10023.57 Crore (standalone) vs ₹9823.58 Crore prior year
  • · Cash and cash equivalents (standalone) rose to ₹298.83 Crore from ₹110.02 Crore as at 31 March 2026
  • · Total standalone assets were ₹90102.20 Crore vs ₹88915.86 Crore as at 31 March 2026
  • · Statutory auditors issued an unmodified limited review report on both standalone and consolidated results
ITC Limited Result mixed materiality 8/10

02-11-2026

ITC reported standalone Revenue from operations of ₹28317.67 Cr for Q2 FY27, up 45.7% YoY from ₹19441.50 Cr, but the growth is inflated by a sharp excise duty increase on cigarettes (₹9916.65 Cr vs ₹1360.74 Cr) following the GST Compensation Cess expiry, making periods not strictly comparable. Standalone Profit for the period fell 20.1% YoY to ₹4137.12 Cr (from ₹5175.70 Cr) and PBT declined 19.9% to ₹5481.75 Cr, with FMCG-Cigarettes segment results down to ₹3813.45 Cr from ₹5240.66 Cr. Consolidated PAT was ₹4229.33 Cr (down 18.5% YoY) while consolidated revenue rose 43.9% to ₹30578.40 Cr; results include the Century Pulp and Paper acquisition (completed 1 Aug 2026) and Sproutlife consolidation, and are not comparable with prior periods.

  • · Excise duty on standalone basis jumped to ₹9916.65 Cr in Q2 FY27 from ₹1360.74 Cr in Q2 FY26 due to GST/Central Excise increase on cigarettes effective 1 February 2026
  • · Standalone FMCG-Cigarettes segment revenue rose to ₹15536.13 Cr from ₹8722.83 Cr YoY, but segment results fell to ₹3813.45 Cr from ₹5240.66 Cr
  • · Agri Business segment revenue declined to ₹4451.69 Cr from ₹3976.24 Cr YoY (up), while six-month Agri revenue fell to ₹12533.75 Cr from ₹13661.27 Cr
  • · Standalone EBITDA for FMCG-Others rose to ₹722.86 Cr from ₹593.45 Cr YoY
  • · Century Pulp and Paper acquisition completed 1 August 2026 on slump sale basis; Paperboards, Paper & Packaging segment assets rose to ₹14026.51 Cr from ₹9779.55 Cr
  • · Sproutlife became a wholly owned subsidiary effective 28 September 2026 after acquisition of additional 13,445 equity shares
  • · Net cash from operating activities (standalone) rose to ₹7765.58 Cr from ₹5738.67 Cr
  • · Dividend paid (standalone) was ₹10023.57 Cr in H1 FY27 vs ₹9823.58 Cr in H1 FY26
  • · Standalone inventories increased to ₹22147.09 Cr as at 30.09.2026 from ₹17931.90 Cr as at 31.03.2026
  • · Total assets (standalone) stood at ₹90102.20 Cr vs ₹88915.86 Cr as at 31.03.2026
ITC Limited Company Update mixed materiality 8/10

03-11-2026

ITC's consolidated revenue rose 19% YoY (LTL 17.3%, ex-Atta 23%) with EBITDA margin expanding 50 bps, marking a 4th consecutive quarter of double-digit growth, led by FMCG at a 14-quarter-high and Paper Segment revenue up 36% YoY (LTL 10%). However, the Cigarettes business saw legal industry volumes remain under pressure from an unprecedented tax increase, and Agri Business growth of 12% YoY was tempered by West Asia conflict-led disruptions and lower domestic leaf tobacco demand tied to the cigarette tax hike.

  • · Cigarettes business: legal industry volumes remain under pressure due to unprecedented tax increase; QoQ performance improved
  • · Sharp increase in seizures of smuggled cigarette consignments by enforcement agencies nationwide
  • · Significant reduction in FCV tobacco crop size announced by the Tobacco Board, likely to severely impact Indian tobacco farmers' earnings
  • · Exports of Agri commodities impacted by West Asia conflict-led disruptions, constrained shipping availability and sharp escalation in ocean freight
  • · Nicotine & nicotine derivative products business (ITC IndiVision Limited) turned PBIT positive in the last 3 quarters
  • · Wood prices remain elevated due to lower-than-expected harvest and competing industry demand; moderation expected going forward
  • · Minimum Import Price on Virgin Multi-layered Paperboard extended till 31st March 2027
  • · Sproutlife Foods Private Limited became a wholly owned subsidiary w.e.f. 28th September 2026
  • · Acquisition of Century Pulp and Paper (CPP) undertaking completed on 1st August 2026
  • · Value-Added atta variants and Staples adjacencies grew three-fold over the last 5 years, with portfolio salience doubling
  • · Deficient and uneven monsoons, lower reservoir levels and strengthening El Niño conditions pose risks to agricultural output and inflation
  • · 24 Mantra organic products exports impacted by transient factors despite robust domestic growth
ITC Limited Company Update neutral materiality 4/10

03-11-2026

ITC Limited's board approved the amalgamation of its wholly owned subsidiary Sproutlife Foods Private Limited (owner of the 'Yoga Bar' brand) with ITC under Sections 230 and 232 of the Companies Act, 2013, effective April 1, 2026, subject to approvals. Sproutlife is small relative to ITC, with turnover of ₹451.71 Cr versus ITC's ₹80,867.49 Cr and net worth of ₹5.22 Cr versus ₹68,434.16 Cr. No new shares will be issued and ITC's shareholding pattern will remain unchanged.

  • · Sproutlife total assets: ₹150.07 Cr; ITC total assets: ₹88,915.86 Cr (FY 2025-26 audited standalone)
  • · Sproutlife turnover: ₹451.71 Cr; ITC turnover: ₹80,867.49 Cr
  • · Sproutlife net worth: ₹5.22 Cr; ITC net worth: ₹68,434.16 Cr
  • · Transaction is a related party transaction as Sproutlife is a wholly owned subsidiary; transfer will be at arm's length
  • · All equity shares of Sproutlife held by ITC and nominees will be cancelled; no fresh ITC shares will be issued
  • · Board meeting commenced at 2:45 p.m. and concluded at 6:05 p.m. on November 2, 2026
  • · Scheme effective date: April 1, 2026, subject to necessary approvals
Marico Limited Analyst/Investor Meet neutral materiality 2/10

02-11-2026

Marico Limited disclosed via a Regulation 30 filing dated November 2, 2026, that the audio recording of its earnings conference call held the same day is now available on the company's website. The call covered the unaudited financial results and operations for the quarter and half year ended September 30, 2026. The transcript will be submitted to the stock exchanges and published subsequently; the filing itself contains no financial figures or performance data.

  • · Scrip Code: 531642 (BSE); Scrip Symbol: MARICO (NSE)
  • · Filing digitally signed on 2026.11.02 at 20:31:12 +05'30'
  • · Audio recording available at https://marico.com/india/investors#quarterly
  • · Transcript to be intimated to stock exchanges subsequently

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 12 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: BSE FMCG Sector Regulatory Filings

🇮🇳 More from India

View all →